News

This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.
Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...
Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...
In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human connections?Come to this talk and discover how a personal touch can take ...
The North Carolina Biotechnology Center awarded eight grants and loans totaling more than $1.2 million to universities and life sciences companies in the second quarter of its current fiscal year.
The North Carolina Research Administrators Alliance (NC RAA) is an all-volunteer network that fosters collaboration, professional growth, and knowledge sharing among research administrators statewide.
This event brings together the next generation of STEM leaders for an evening of meaningful connection, career discovery and insight. Join fellow interns and engage with professionals across the ...
Join Innovate Carolina’s Office of Technology Commercialization for its 2025 Celebration of Inventorship, an evening dedicated to recognizing UNC’s distinguished inventors. This event will feature ...
Charlotte’s Health Innovation Pitch Party is a dynamic, high-energy event designed to spotlight the greater Charlotte region's growing healthtech ecosystem. This event will bring together six ...
Using Chatbots, especially AI-powered ones, can increase productivity and make your business work faster. However, they come with a degree of risk as well as reward. Attend Unlocking AI: Mastering ...
The NC BioPharma Networking group will host its next meeting on Tuesday, April 22, at Rosecomb Beer Garden in Cary. All are welcome, particularly those involved with cell and gene therapy, biologics, ...